Spirulina is exceptionally rich in phycocyanobilin (PCB), which recently has been shown to
act as a potent inhibitor of NADPH oxidase; this effect likely rationalizes the broad range of antiinflammatory, cytoprotective, and antiatherosclerotic effects which orally administered spirulina has achieved in rodent studies.